Copyright
©2014 Baishideng Publishing Group Inc.
World J Transl Med. Aug 12, 2014; 3(2): 58-68
Published online Aug 12, 2014. doi: 10.5528/wjtm.v3.i2.58
Published online Aug 12, 2014. doi: 10.5528/wjtm.v3.i2.58
Ref. | Year | DCD transplants number | Recipient survival rate (%) at 1 yr, 3 yr, and 5 yr post-transplant | Graft survival rate (%) at 1 yr, 3 yr, and 5 yr post-transplant | ITBS rate | Retransplants rate | ||||
Croome et al[98] | 2013 | HCC DCD = 242 | 76 | 64 | 56 | |||||
Non-HCC DCD = 2117 | 86 | 77 | 71 | |||||||
Abt et al[33] | 2013 | 110 | 47 | 14% | ||||||
Callaghan et al[99] | 2013 | 352 | 81 | 73 | ||||||
Vanatta et al[100] | 2013 | 38 | 92 | 80 | 92 | 74 | 7% | 2% | ||
Elaffandi et al[101] | 2012 | 108 | 84 | 2% | ||||||
Taner et al[28] | 2012 | 200 | 93 | 85 | 81 | 81 | 73 | 69 | 12% | 5% |
Meurisse et al[52] | 2012 | 30 | 93 | 85 | 85 | 90 | 82 | 82 | 3% | |
DeOliveira et al[30] | 2011 | 167 | 87 | 85 | 81 | 85 | 83 | 78 | 2% | |
Hong et al[102] | 2011 | 81 | 78 | 62 | 53 | 10% | 12% | |||
Mathur et al[53] | 2011 | 1567 | 65 | 13% | ||||||
Dubbled et al[46] | 2010 | 55 | 85 | 80 | 74 | 68 | 14% | 18% | ||
Yamamoto et al[45] | 2010 | 24 | 62 | 43 | 43 | 54 | 37 | 38 | ||
Detry et al[103] | 2010 | 58 | 83 | 67 | 72 | 49 | 38% | |||
de Vera et al[27] | 2009 | 141 | 79 | 70 | 69 | 56 | 16% | 18% | ||
Grewal et al[43] | 2009 | 108 | 92 | 88 | 88 | 79 | 74 | 71 | 8% | 15% |
Jiménez-Galanes et al[104] | 2009 | 20 | 86 | 80 | 5% | |||||
Pine et al[105] | 2009 | 39 | 82 | 68 | 80 | 64 | 20% | |||
Nguyen et al[42] | 2009 | 19 | 90 | 90 | 74 | 63 | 10% | 16% | ||
Fujita et al[106] | 2007 | 24 | 87 | 82 | 69 | 56 | 21% |
Hypothermic machine perfusion HMP | Normothermic machine perfusion NMP |
Temperature 0 °C-4 °C | Temperature 37 °C |
Logistically easier | Logistically demanding |
Modest resumption of energy production with low perfusion rate | |
Improves the state of mitochondria during preservation | Recreates the physiological milieu by maintenance of normal temperature |
Performed at sub-physiologic pressures[107] | Performed at physiological pressures[70,82] |
Requires low perfusion rates[108] | Requires high perfusion rates[108] |
No requirement for a specific oxygen carrier in the perfusate as demand for O2 is low[108] | Oxygen is provided by using blood, modified hemoglobin, or using a high oxygen tension in special preservation solutions[70,82,84,88,109] |
Less occurrence of graft infection considering the hypothermic state More tendency for endothelial cell, kupffer cell, and macrophage cell damage due to shear stress and hypothermic activation[110-113] | Reduces IRI |
When compared to SCS it decreases inflammatory cytokines but no difference in graft or patient survival was found[77,114] | Provides nutrients (glucose, amino acids, etc.), medications to prevent micro-circulatory failure (e.g., prostacyclin, heparin, antibiotics), and oxygen |
May help protect marginal livers by converting PNF into allograft dysfunction[71] | Allows the assessment of organ viability (e.g., Galactose elimination, factor V production, bile flow) |
May allow the use of gene therapy prior to transplantation, to reduce the risk of rejection, or decrease the ischemia-reperfusion injury[115-117] |
- Citation: Bazerbachi F, Selzner N, Seal JB, Selzner M. Liver transplantation with grafts obtained after cardiac death-current advances in mastering the challenge. World J Transl Med 2014; 3(2): 58-68
- URL: https://www.wjgnet.com/2220-6132/full/v3/i2/58.htm
- DOI: https://dx.doi.org/10.5528/wjtm.v3.i2.58